7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Dyslipidemia
Dyslipidemia is a medical condition marked by an abnormal lipid profile, encompassing cholesterol and triglycerides in the bloodstream. Its significance lies in its association with the development of cardiovascular diseases, notably atherosclerosis and coronary artery disease. This condition arises from disruptions in lipid production, utilization, or clearance, resulting in elevated levels of LDL cholesterol, often termed "bad" cholesterol, and decreased levels of HDL cholesterol, referred to as "good" cholesterol. Contributing factors to dyslipidemia include a combination of genetic predisposition, lifestyle choices, and underlying health conditions. Unhealthy dietary patterns, sedentary lifestyle, and obesity play substantial roles in its onset.
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation